📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Inotiv

1.1 - Company Overview

Inotiv Logo

Inotiv

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical analytical, reproductive toxicology, and medical device testing, offering in vivo preclinical efficacy and toxicity, DMPK method development and bioanalysis, genetic toxicology, histology, and anatomical, clinical, and medical device pathology, plus consulting in DMPK data analysis, biomarker analysis, and bioequivalence to support biologic and small molecule drug development from discovery to First-in-Human.

Products and services

  • Drug Metabolism and Pharmacokinetics (DMPK): Supplies bioanalytical, R&D-spanning services for method development, metabolite identification, and pharmacokinetic studies across all stages of R&D
  • In Vivo Services: Produces preclinical efficacy and toxicity data supporting advancement of biologic and small molecule drugs from discovery through First‑in‑Human studies
  • Pathology: Delivers anatomical, clinical, and medical-device pathology services, including routine histochemistry, IHC, IF, and ISH

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Inotiv

Vibalogics Logo

Vibalogics

HQ: Germany Website
  • Description: Provider of contract development and manufacturing services for live biological products, including process development, manufacturing and fill & finish for oncolytic viruses, gene therapies and vaccines. Capabilities span viral vector and live virus production, RNA and LNP manufacturing, plasmid development and manufacturing, upstream/downstream and formulation development, and cGMP manufacturing for phase 1–2 clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vibalogics company profile →
Grand River Aseptic Manufacturing Logo

Grand River Aseptic Manufacturing

HQ: United States Website
  • Description: Provider of parenteral contract development and manufacturing services, delivering customized aseptic fill-finish for liquid and lyophilized vials, syringes, and cartridges from development through commercialization. Offers advanced filling lines with isolator technology, flexible Bausch+Ströbel VarioSys systems, analytical testing and regulatory filing support for biologics, small molecules, and vaccines, plus inspection, packaging, and warehouse capabilities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grand River Aseptic Manufacturing company profile →
BioStrata Logo

BioStrata

HQ: United Kingdom Website
  • Description: Provider of life science marketing services delivered by a team fluent in scientific and business languages, including brand awareness, lead generation and customer conversion; scientific and technical content creation; SEO (keyword research, content optimization, performance tracking); public relations; and marketing strategy development based on market research and tactical planning.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioStrata company profile →
Vectura Logo

Vectura

HQ: United Kingdom Website
  • Description: Provider of inhalation drug delivery services; formulation development for inhalers, nebulisers, and nasal sprays; comprehensive pharmaceutical analysis; in-house manufacturing of drug products and medical devices for development studies and clinical trials; device platforms for DPI, pMDI, and nebuliser technologies; and process development and technical transfer for airways-related diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vectura company profile →
Genetic Logo

Genetic

HQ: Italy Website
  • Description: Provider of integrated pharmaceutical research, development, manufacturing and licensing of pharmaceutical specialties and medical devices, focused on respiratory and ophthalmology. Offers proprietary medicines (nebulization and oral liquids, tablets, capsules), ophthalmic and respiratory products (pMDI, nebulizers), preservative-free eye drops and nasal sprays, out-licensing/third-party production, and pharmacovigilance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genetic company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Inotiv

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Inotiv

2.2 - Growth funds investing in similar companies to Inotiv

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Inotiv

4.2 - Public trading comparable groups for Inotiv

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Inotiv

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Inotiv

What does Inotiv do?

Inotiv is a provider of biopharmaceutical analytical, reproductive toxicology, and medical device testing, offering in vivo preclinical efficacy and toxicity, DMPK method development and bioanalysis, genetic toxicology, histology, and anatomical, clinical, and medical device pathology, plus consulting in DMPK data analysis, biomarker analysis, and bioequivalence to support biologic and small molecule drug development from discovery to First-in-Human.

Who are Inotiv's competitors?

Inotiv's competitors and similar companies include Vibalogics, Grand River Aseptic Manufacturing, BioStrata, Vectura, and Genetic.

Where is Inotiv headquartered?

Inotiv is headquartered in United States.

How many employees does Inotiv have?

Inotiv has 1,000 employees 🔒.

When was Inotiv founded?

Inotiv was founded in 2010 🔒.

What sector and industry vertical is Inotiv in?

Inotiv is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Inotiv

Who are the top strategic acquirers in Inotiv's sector and industry

Top strategic M&A buyers and acquirers in Inotiv's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Inotiv?

Top strategic M&A buyers groups and sectors for Inotiv include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Inotiv's sector and industry vertical

Which are the top PE firms investing in Inotiv's sector and industry vertical?

Top PE firms investing in Inotiv's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Inotiv's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Inotiv's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Inotiv's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Inotiv include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Inotiv's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Inotiv?

The key public trading comparables and valuation benchmarks for Inotiv include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Inotiv for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Inotiv with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Inotiv's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Inotiv with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Inotiv's' sector and industry vertical?

Access recent funding rounds and capital raises in Inotiv's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Inotiv

Launch login modal Launch register modal